- Home
- SYTA vs CLGN Comparison
SYTA vs CLGN Comparison
Compare SYTA & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- CLGN
- Stock Information
- Founded
- SYTA N/A
- CLGN 2004
- Country
- SYTA Canada
- CLGN Israel
- Employees
- SYTA N/A
- CLGN N/A
- Industry
- SYTA Telecommunications Equipment
- CLGN Industrial Specialties
- Sector
- SYTA Telecommunications
- CLGN Health Care
- Exchange
- SYTA Nasdaq
- CLGN Nasdaq
- Market Cap
- SYTA 38.2M
- CLGN 33.8M
- IPO Year
- SYTA 2020
- CLGN N/A
- Fundamental
- Price
- SYTA $2.49
- CLGN $2.66
- Analyst Decision
- SYTA
- CLGN Strong Buy
- Analyst Count
- SYTA 0
- CLGN 2
- Target Price
- SYTA N/A
- CLGN $11.50
- AVG Volume (30 Days)
- SYTA 398.4K
- CLGN 30.5K
- Earning Date
- SYTA 11-13-2025
- CLGN 08-20-2025
- Dividend Yield
- SYTA N/A
- CLGN N/A
- EPS Growth
- SYTA N/A
- CLGN N/A
- EPS
- SYTA N/A
- CLGN N/A
- Revenue
- SYTA $11,883,835.00
- CLGN $2,402,000.00
- Revenue This Year
- SYTA $18.41
- CLGN $1,617.28
- Revenue Next Year
- SYTA N/A
- CLGN $83.54
- P/E Ratio
- SYTA N/A
- CLGN N/A
- Revenue Growth
- SYTA 49.13
- CLGN 248.62
- 52 Week Low
- SYTA $0.93
- CLGN $1.31
- 52 Week High
- SYTA $29.20
- CLGN $5.00
- Technical
- Relative Strength Index (RSI)
- SYTA 40.56
- CLGN 52.88
- Support Level
- SYTA $2.42
- CLGN $2.38
- Resistance Level
- SYTA $2.78
- CLGN $2.77
- Average True Range (ATR)
- SYTA 0.21
- CLGN 0.18
- MACD
- SYTA -0.01
- CLGN -0.02
- Stochastic Oscillator
- SYTA 29.02
- CLGN 47.46
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.